We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
+32.42%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$703M
AUM Growth
+$202M
(+40%)
Cap. Flow
+$117M
Cap. Flow
% of AUM
16.67%
Top 10 Holdings %
Top 10 Hldgs %
43.13%
Holding
134
New
60
Increased
28
Reduced
13
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$12.9M |
| 2 |
Dentsply Sirona
XRAY
|
+$9.25M |
| 3 |
Boston Scientific
BSX
|
+$7.14M |
| 4 |
VRAY
ViewRay, Inc.
VRAY
|
+$7.09M |
| 5 |
Gilead Sciences
GILD
|
+$6.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SI-BONE Inc
SIBN
|
+$4.49M |
| 2 |
Amgen
AMGN
|
+$3.89M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.33M |
| 4 |
Tandem Diabetes Care
TNDM
|
+$2.99M |
| 5 |
AMRN
Amarin Corp
AMRN
|
+$2.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.29% |
| 2 | Industrials | 0.63% |
| 3 | Financials | 0.27% |
| 4 | Technology | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$821B
| $87.6M | 12.45% |
310,000
-182,000
| -37% | -$49.4M |
|
2
PUT
iShares Russell 2000 ETF
IWM
$83B
| $67.7M | 9.63% |
442,500
+17,500
| +4% | +$2.63M |
|
3
PUT
First Trust Health Care AlphaDEX Fund
FXH
$1.06B
| $28.7M | 4.07% |
375,000
-75,000
| -17% | -$5.59M |
|
|
4
CALL
Zimmer Biomet
ZBH
$18.5B
| $22.3M | 3.18% |
+180,250
| New | +$20.5M |
|
5
Inspire Medical Systems
INSP
$1.85B
| $20.4M | 2.89% |
358,500
-4,173
| -1% | -$225K |
|
6
ICU Medical
ICUI
$4.3B
| $17.6M | 2.51% |
73,619
+8,500
| +13% | +$2.04M |
|
|
NSTG
7
DELISTED
NanoString Technologies, Inc.
NSTG
| $15.6M | 2.22% |
651,441
+55,049
| +9% | +$1.26M |
|
8
PUT
UnitedHealth
UNH
$370B
| $14.8M | 2.11% |
+60,000
| New | +$15.3M |
|
9
PUT
Amplify Alternative Harvest ETF
MJ
$104M
| $14.5M | 2.07% |
33,333
-10,250
| -24% | -$4.22M |
|
|
10
Zimmer Biomet
ZBH
$18.5B
| $14M | 2% |
+113,300
| New | +$12.9M |
|
11
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
| $13.8M | 1.96% |
150,000
| – | – |
|
|
12
CALL
Dentsply Sirona
XRAY
$2.86B
| $12.4M | 1.76% |
+250,000
| New | +$11M |
|
13
PUT
iShares US Medical Devices ETF
IHI
$3.36B
| $11.6M | 1.65% |
+300,000
| New | +$10.9M |
|
|
14
Dentsply Sirona
XRAY
$2.86B
| $10.4M | 1.48% |
+210,000
| New | +$9.25M |
|
15
STAAR Surgical
STAA
$1.2B
| $10.1M | 1.43% |
294,842
+96,586
| +49% | +$3.42M |
|
16
PUT
Myriad Genetics
MYGN
$303M
| $9.96M | 1.42% |
+300,000
| New | +$9.13M |
|
17
CALL
Stryker
SYK
$129B
| $9.88M | 1.4% |
+50,000
| New | +$9M |
|
18
PUT
Edwards Lifesciences
EW
$51.6B
| $9.57M | 1.36% |
+150,000
| New | +$8.56M |
|
|
VRAY
19
DELISTED
ViewRay, Inc.
VRAY
| $8.84M | 1.26% |
1,196,805
+920,000
| +332% | +$7.09M |
|
20
Guardant Health
GH
$21.4B
| $8.73M | 1.24% |
113,800
+3,437
| +3% | +$191K |
|
|
21
PUT
Guardant Health
GH
$21.4B
| $8.73M | 1.24% |
+113,800
| New | +$6.31M |
|
22
CALL
Qiagen
QGEN
$8.73B
| $8.14M | 1.16% |
+188,611
| New | +$7.59M |
|
|
23
Boston Scientific
BSX
$71.1B
| $8.06M | 1.15% |
210,000
+186,965
| +812% | +$7.14M |
|
24
CALL
Smith & Nephew
SNN
$12.8B
| $8.02M | 1.14% |
+200,000
| New | +$7.69M |
|
25
Establishment Labs
ESTA
$2.78B
| $7.73M | 1.1% |
321,725
+34,326
| +12% | +$911K |
|
Similar funds
GMP
BCA
ONGA
RC
DOFI
SR
TC
PA
Pura Vida Investments's Q1 2019 Portfolio in Review
As of Q1 2019, Pura Vida Investments held 134 positions worth $703M, up 40% from $501M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Pura Vida Investments deployed $117M of net new capital in Q1 2019, opening 60 new positions and adding to 28 existing holdings. Its largest new stake was Zimmer Biomet: 113,300 shares worth $14M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 28% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Tandem Diabetes Care, an estimated $2.99M trimmed.
- Pura Vida Investments's largest Q1 2019 buy was Zimmer Biomet: 113,300 shares worth $14M.
- Pura Vida Investments added most to Boston Scientific in Q1 2019, an estimated $7.14M increase.
- Pura Vida Investments's biggest Q1 2019 reduction was Tandem Diabetes Care, cutting an estimated $2.99M.
- Pura Vida Investments fully exited SI-BONE Inc in Q1 2019, selling an estimated $4.49M.
- Pura Vida Investments's ten largest holdings make up 43% of its $703M portfolio in Q1 2019.
- Pura Vida Investments opened 60 new positions and closed 31 in Q1 2019.
- Pura Vida Investments's portfolio value rose 40% quarter-over-quarter to $703M.
Based on Pura Vida Investments's 13F filing for Q1 2019, filed 14 May 2019.